Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Novartis AG (NVS) vs Carparts.Com Inc (PRTS) Price & Performance

Novartis AGTrade
Carparts.Com IncTrade

Price performance (Past 24H)

Key statistics

Novartis AG vs Carparts.Com Inc — how do they compare? Novartis AG trades at $137.61 (market cap $262.64B), while Carparts.Com Inc trades at $10.2 (market cap $72.26M). The key difference: Novartis AG is far larger — about 3634.7× Carparts.Com Inc's market cap, and Novartis AG pays a 3.44% dividend while Carparts.Com Inc pays none. Which is the better fit depends on your goals.

NVSPRTS
Market Cap
$262.64B$72.26M
Sector
HealthConsumer Cyclical
52-Week High
$168.62$10.00
52-Week Low
$121.80$3.88
Enterprise Value
$303.97B$85.23M
Dividend Yield
3.44%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Novartis AG

Novartis (NVS) is trading at $137.70, down 13.93% following significant clinical trial setbacks for del-desiran and pelacarsen. The stock shows bearish technical signals with support at $133-$136 and resistance at $140-$143. Fundamentally, the company maintains strong profitability with 74.74% gross margins and 22.5% net income margins, though recent pipeline failures have overshadowed solid financial performance.

While Novartis maintains strong financial fundamentals and reiterated 2025-2030 growth guidance, the recent clinical trial failures create near-term uncertainty. The stock faces pressure from pipeline setbacks but offers value at current levels for long-term investors willing to weather development risks. Analyst consensus remains cautious with 68% hold ratings.

Carparts.Com Inc

CarParts.com (PRTS) trades at $9.50, up 2.15% with strong technical momentum and bullish moving average signals. The company shows improving quarterly earnings performance with three consecutive beats, though it remains unprofitable with negative margins. Recent developments include a new $25 million credit facility and Nasdaq compliance restoration, while analyst sentiment leans positive with 60% buy ratings.

The outlook suggests cautious optimism given improving earnings trajectory and technical strength, but significant risks persist from sustained losses, negative cash flow, and competitive pressures. Investment appeal hinges on the company's ability to translate revenue stabilization into profitability while managing operational challenges in the automotive e-commerce sector.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Novartis AG

Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.

Read more on NVS

About Carparts.Com Inc

CarParts.com Inc is an online provider of automotive aftermarket parts and repair information. The company principally sells its products to individual consumers through its network of websites and online marketplaces. The company's products consist of collision parts serving the body repair market, engine parts to serve the replacement parts market, and performance parts and accessories.

Read more on PRTS